APA

Amatya V. J., Kushitani K., Kai Y., Suzuki R., Miyata Y., Okada M. & Takeshima Y. (20190415). Glypican-1 immunohistochemistry is a novel marker to differentiate epithelioid mesothelioma from lung adenocarcinoma. : Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

Chicago

Amatya Vishwa Jeet, Kushitani Kei, Kai Yuichiro, Suzuki Rui, Miyata Yoshihiro, Okada Morihito and Takeshima Yukio. 20190415. Glypican-1 immunohistochemistry is a novel marker to differentiate epithelioid mesothelioma from lung adenocarcinoma. : Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

Harvard

Amatya V. J., Kushitani K., Kai Y., Suzuki R., Miyata Y., Okada M. and Takeshima Y. (20190415). Glypican-1 immunohistochemistry is a novel marker to differentiate epithelioid mesothelioma from lung adenocarcinoma. : Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

MLA

Amatya Vishwa Jeet, Kushitani Kei, Kai Yuichiro, Suzuki Rui, Miyata Yoshihiro, Okada Morihito and Takeshima Yukio. Glypican-1 immunohistochemistry is a novel marker to differentiate epithelioid mesothelioma from lung adenocarcinoma. : Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc. 20190415.